Olli Jarva, Synopsys’s Software Integrity Group managing consultant, opined that hackers find healthcare data of more value than credit card or social security details, referring to the recent ransomware attack on Singapore’s government health database.
The research team from Stanford University have invented a novel wearable that could measure the level of a patient’s cortisol from their sweat. Cortisol is a hormone linked to stress, which takes several days to test. This scientific discovery was recently published in Science Advances.
Matt Hancock, new Health and Social Care Secretary, announced that information technology would be among his prime subject of focus for the betterment of National Health Service.
An organized cyberattack on the Singapore government’s health database caused a leak of 1.5 million patients’ records, including Prime Minister Lee Hsien Loong, for nearly an entire week.
Telemedicine helps Nashville-based Vanderbilt University Medical Center take its kidney transplant program to the people of Tennessee and give them the prospect to be screened for a transplant and bring constant care within their reach.
LabCorp, the mammoth medical investigations company, is still recuperating from a major ransomware attack and, almost a week later, won’t reveal how the hackers got entry nor the number of servers that were hit.
Artificial intelligence based company Viz.ai, currently developing software for the detection of urgent stroke cases, has recently raised $21 million in venture capital to develop its portfolio.
K, a new free primary care app was launched by the individualized health information company, K Health. The app’s AI scours through the history of diagnoses and treatments to provide the user with the most likely treatment of their condition and can simultaneously connect them to a network of primary health care providers.
A five-year engineering pact between Walmart and Microsoft was signed on Tuesday to clash with Amazon in the AI, cloud computing and retail sectors.
San Francisco based Verge Genomics, the Neuroscience based drug discovery company launched in 2015, has raised $32 million in early venture capital financing to bring its AI-generated compounds against Parkinson’s disease and amyotrophic lateral sclerosis (ALS) to clinics within the next three years.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.